Skip to content

The Study on the Effect of Acetaminophen on Postoperative Delirium in Orthopedic Surgery by its Analgesic Action

The Study on the Effect of Acetaminophen on Postoperative Delirium in Orthopedic Surgery by its Analgesic Action

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs041220161
Enrollment
300
Registered
2023-04-01
Start date
2023-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orthopedic disease Orthopedic surgery

Interventions

For the acetaminophen treated group, acetaminophen is administered as a postoperative analgesic at a dose of 1000 mg intravenously over 15 minutes at the time of wound closure for patients weighing 50
Acetaminophen, open-label

Sponsors

Nakashima Hiroaki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Over 18 years old Patients undergoing orthopedic surgery under general anesthesia The patient must understand the study and give written consent. Patients must be able to maintain major organ function and meet all of the following criteria (1) AST Less than 5 times the upper limit of the institutional reference value (2) ALT Less than 5 times the upper limit of the institutional reference value (3) Total bilirubin Less than 3 times the upper limit of the institutional reference value (4) Creatinine Less than 3 times the upper limit of the institutional reference value (5) No occurrence of events that, in the judgment of the investigator, would make it difficult to administer the study drug.

Exclusion criteria

Exclusion criteria: Symptoms of Grade 3 or higher (CTCAE v5.0) or abnormal laboratory values Patients with a history of hypersensitivity or intolerance to acetaminophen or NSAIDs Patients with a history of hypersensitivity or intolerance to acetaminophen or NSAIDs. Patients with peptic ulcer. Patients with serious blood disorders. Patients with serious hepatic disorder. Patients with serious renal failure. Patients with serious cardiac dysfunction. Patients with aspirin asthma (non-steroidal anti-inflammatory analgesics induced asthma attack) or a history of aspirin asthma. Patients who are judged by the principal investigator to be unsuitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Incidence of delirium according to CAM Japanese version

Secondary

MeasureTime frame
Postoperative pain VAS (6, 24, 48 hours, 3, 7 days postoperatively) Therapeutic acetaminophen administration up to 48 hours postoperatively for acetaminophen non-treatment group Total opioid dose during hospitalization Time from postoperative to discharge Presence of psychiatric intervention at the time of delirium

Contacts

Public ContactSadayuki Ito

Orthopedic Surgery

sadaito@med.nagoya-u.ac.jp+81-52-741-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026